Business Standard

Reliance Industries rises on heavy volumes

As of December 24, 2012 the company has purchased 46.22 million equity shares at a total consideration of Rs 3,359 crore from public shareholders.

Read more on:    Ril | Buyback | Oil And Gas
Related News

Reliance Industries () is trading higher by about 2% at Rs 856 on back of heavy volumes on the Bombay Stock Exchange. The stock opened at Rs 841 and has seen a combined around 1.55 million shares changing hands on the counter in early noon deals against an average sub 2.5 million shares that were traded daily in past two weeks on both the exchanges.

The stock of Mukesh Ambani-led integrated firm has rallied 4.3% in past four trading sessions on report that natural gas producers like Reliance Industries should be allowed to charge market prices. The Bombay Stock Exchange benchmark index Sensex has gained 2.1% during the same period.

According to PTI report “The 12th Five Year (2012-17) Plan adopted by National Development Council (NDC), headed by the Prime Minister said, "Natural gas prices charged to producers must be determined by market forces.”

Currently, majority of the natural gas produced in the country is priced at $4.2 per million British thermal unit, which is almost a third of the rate at which gas in its liquid form, called liquefied natural gas or LNG, is imported, added report.

Meanwhile, the company informed the stock exchanges that, As of December 24, 2012 it has purchased 46.22 million equity shares at a total consideration of Rs 3,359 crore from public shareholders since it launched a buy-back in February 2012.

RIL has targeted the maximum payout at Rs 10,440 crore for , which would end on January 19, 2013.

Read more on:   
|
|

Read More

Former CJI Kapadia joins BSE

Nominated to post by Sebi, takes over as public interest director

Quick Links

 

Market News

Cardamom up 0.7% on strong demand

Spice for delivery in June gained 0.38%

Palm oil down 0.3% on subdued demand

Oil for delivery in May traded lower by 0.15%

Natco extends gains on US court ruling over generic Copaxone

US Supreme Court ruling paved the way to launch generic version of Teva's Copaxone

Shasun Pharma zooms 40% in three days ahead of board meeting

The board is scheduled to meet today to consider issuing convertible warrants/equity shares on a preferential basis to the promoters.

Mentha oil up 0.4% on pick-up in demand

Oil for April contract traded higher by 0.45%

Back to Top